Bank of Nova Scotia Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,255
Closed -$406K 126
2018
Q3
$406K Sell
5,255
-246
-4% -$18.2K 0.04% 88
2018
Q2
$372K Sell
5,501
-264
-5% -$18.2K 0.04% 90
2018
Q1
$418K Sell
5,765
-2,377
-29% -$181K 0.05% 86
2017
Q4
$613K Sell
8,142
-62,895
-89% -$4.75M 0.07% 77
2017
Q3
$5.46M Sell
71,037
-45,216
-39% -$3.41M 0.58% 38
2017
Q2
$8.7M Buy
116,253
+1,544
+1% +$109K 0.99% 22
2017
Q1
$7.63M Buy
114,709
+3,727
+3% +$248K 0.86% 28
2016
Q4
$7.24M Buy
110,982
+2,794
+3% +$181K 0.83% 26
2016
Q3
$7.65M Buy
108,188
+12,735
+13% +$928K 0.91% 23
2016
Q2
$7.06M Buy
95,453
+60,168
+171% +$4.16M 0.92% 25
2016
Q1
$2.29M Buy
+35,285
New +$2.4M 0.31% 53
2015
Q4
Sell
-2,621
Closed -$216K 117
2015
Q3
$216K Hold
2,621
0.03% 111
2015
Q2
$234K Sell
2,621
-163
-6% -$15K 0.03% 116
2015
Q1
$246K Buy
2,784
+362
+15% +$32.1K 0.03% 107
2014
Q4
$201K Buy
2,422
+11
+0.5% +$912 0.02% 111
2014
Q3
$203K Buy
+2,411
New +$195K 0.02% 115

Other funds holding NVS

Bank of Nova Scotia Trust's NVS Position: Q4 2018 in Review

Bank of Nova Scotia Trust sold out of Novartis (NVS) in Q4 2018, closing a stake of 5,255 shares — an estimated $406K sold.

Bank of Nova Scotia Trust first reported a position in NVS in Q3 2014 and held it in 16 quarters. The position peaked at $8.7M in Q2 2017. 1,088 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

  • Bank of Nova Scotia Trust reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 5,255 Novartis shares in Q4 2018, an estimated $406K.
  • Bank of Nova Scotia Trust first reported a position in Novartis in Q3 2014 and held it in 16 quarters.
  • Bank of Nova Scotia Trust's Novartis position peaked at $8.7M in Q2 2017.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2018, filed 11 Feb 2019.